438 related articles for article (PubMed ID: 9375960)
1. Cardiovascular and behavioural effects of intracerebroventricularly administered tachykinin NK3 receptor antagonists in the conscious rat.
Cellier E; Barbot L; Regoli D; Couture R
Br J Pharmacol; 1997 Oct; 122(4):643-54. PubMed ID: 9375960
[TBL] [Abstract][Full Text] [Related]
2. Cardiovascular and behavioural effects of centrally administered tachykinins in the rat: characterization of receptors with selective antagonists.
Picard P; Regoli D; Couture R
Br J Pharmacol; 1994 May; 112(1):240-9. PubMed ID: 7518304
[TBL] [Abstract][Full Text] [Related]
3. The ventral tegmental area as a putative target for tachykinins in cardiovascular regulation.
Deschamps K; Couture R
Br J Pharmacol; 2005 Jul; 145(6):712-27. PubMed ID: 15895109
[TBL] [Abstract][Full Text] [Related]
4. Study of SR 142801, a new potent non-peptide NK3 receptor antagonist on cardiovascular responses in conscious guinea-pig.
Roccon A; Marchionni D; Nisato D
Br J Pharmacol; 1996 Jul; 118(5):1095-102. PubMed ID: 8818331
[TBL] [Abstract][Full Text] [Related]
5. SR142801 behaves as a tachykinin NK-3 receptor agonist on a spinal nociceptive reflex in the rat.
Couture R; Toma N; Barbot L
Life Sci; 2000; 66(1):51-65. PubMed ID: 10658924
[TBL] [Abstract][Full Text] [Related]
6. In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists.
Medhurst AD; Hay DW; Parsons AA; Martin LD; Griswold DE
Br J Pharmacol; 1997 Oct; 122(3):469-76. PubMed ID: 9351503
[TBL] [Abstract][Full Text] [Related]
7. Localization of Fos-like immunoreactivity induced by the NK3 tachykinin receptor agonist, senktide, in the guinea-pig brain.
Yip J; Chahl LA
Br J Pharmacol; 1997 Oct; 122(4):715-25. PubMed ID: 9375969
[TBL] [Abstract][Full Text] [Related]
8. Modulation of cardiac activity by tachykinins in the rat substantia nigra.
Lessard A; Couture R
Br J Pharmacol; 2001 Dec; 134(8):1749-59. PubMed ID: 11739252
[TBL] [Abstract][Full Text] [Related]
9. Central tachykinin NK3 receptors in the inhibitory action on the rat colonic propulsion of a new tachykinin, PG-KII.
Broccardo M; Improta G; Tabacco A
Eur J Pharmacol; 1999 Jul; 376(1-2):67-71. PubMed ID: 10440091
[TBL] [Abstract][Full Text] [Related]
10. Intracerebroventricular responses to neuropeptide gamma in the conscious rat: characterization of its receptor with selective antagonists.
Picard P; Couture R
Br J Pharmacol; 1996 Jan; 117(2):241-9. PubMed ID: 8789375
[TBL] [Abstract][Full Text] [Related]
11. Characterization of central and peripheral effects of septide with the use of five tachykinin NK1 receptor antagonists in the rat.
Cellier E; Barbot L; Iyengar S; Couture R
Br J Pharmacol; 1999 Jun; 127(3):717-28. PubMed ID: 10401563
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and behavioural effects of centrally administered neuropeptide K in the rat: receptor characterization.
Prat A; Picard P; Couture R
Br J Pharmacol; 1994 May; 112(1):250-6. PubMed ID: 7518305
[TBL] [Abstract][Full Text] [Related]
13. Functional interaction between losartan and central tachykinin NK3 receptors in the conscious rat.
Picard P; Chrétien L; Couture R
Br J Pharmacol; 1995 Apr; 114(8):1563-70. PubMed ID: 7541280
[TBL] [Abstract][Full Text] [Related]
14. Effects of the tachykinin NK1 receptor antagonist, RP 67580, on central cardiovascular and behavioural effects of substance P, neurokinin A and neurokinin B.
Culman J; Wiegand B; Spitznagel H; Klee S; Unger T
Br J Pharmacol; 1995 Mar; 114(6):1310-6. PubMed ID: 7542533
[TBL] [Abstract][Full Text] [Related]
15. Receptors mediating tachykinin-evoked depolarisations of neurons in the neonatal rat spinal cord.
Fox AJ; Naeem S; Patel IA; Walpole C; Urbán L
Acta Biol Hung; 1996; 47(1-4):129-44. PubMed ID: 9123986
[TBL] [Abstract][Full Text] [Related]
16. Senktide-induced gerbil foot tapping behaviour is blocked by selective tachykinin NK1 and NK3 receptor antagonists.
Sundqvist M; Kristensson E; Adolfsson R; Leffler A; Ahlstedt I; Engberg S; Drmota T; Sigfridsson K; Jussila R; de Verdier J; Novén A; Johansson A; Påhlman I; von Mentzer B; Lindström E
Eur J Pharmacol; 2007 Dec; 577(1-3):78-86. PubMed ID: 17920583
[TBL] [Abstract][Full Text] [Related]
17. Characterization of tachykinin receptors mediating plasma extravasation and vasodilatation in normal and acutely inflamed knee joints of the rat.
Lam FY; Wong MC
Br J Pharmacol; 1996 Aug; 118(8):2107-14. PubMed ID: 8864549
[TBL] [Abstract][Full Text] [Related]
18. Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.
Piot O; Betschart J; Grall I; Ravard S; Garret C; Blanchard JC
Br J Pharmacol; 1995 Nov; 116(5):2496-502. PubMed ID: 8581290
[TBL] [Abstract][Full Text] [Related]
19. Effect of tachykinin receptor inhibition in the brain on cardiovascular and behavioral responses to stress.
Culman J; Klee S; Ohlendorf C; Unger T
J Pharmacol Exp Ther; 1997 Jan; 280(1):238-46. PubMed ID: 8996202
[TBL] [Abstract][Full Text] [Related]
20. Effect of SR 142801 on nitric oxide-dependent and independent responses to tachykinin NK3 receptor agonists in isolated guinea-pig colon.
Giuliani S; Maggi CA
Naunyn Schmiedebergs Arch Pharmacol; 1995 Nov; 352(5):512-9. PubMed ID: 8751080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
